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N-Acylethanolamines as Novel Alcohol Dehydrogenase 3 Substrates
Milena Ivkovic
ABSTRACT
N-Acylethanolamines (NAEs) are a class of fatty acid amides that act as important
mammalian signaling molecules. N-Arachidonoylethanolamine is the best-studied
representative and is one of the endogenous ligands for endocannabinoid receptors. NAEs
play a role in the regulation of appetite, act as anti-inflammatory and analgesic agents,
and are thought to have a neuroprotective function as well. They have been proposed to
also serve as precursors to N-acylglycines (NAGs). N-Acylglycinals are likely to be
intermediates between the NAEs and the NAGs. The sequential actions of a putative fatty
alcohol dehydrogenase and a putative fatty aldehyde dehydrogenase are thought to affect
the NAD+-dependent oxidation of the NAEs to the NAGs. NAGs, in turn, serve as
precursor in the biosynthesis of primary fatty acid amides (PFAMs), another class of
mammalian regulatory molecules. Alcohol dehydrogenase 3 (ADH3), an enzyme known
to oxidize mid- and long-chain alcohols to aldehydes, was evaluated for its potential in
oxidation of NAEs to N-acylglycinals.
In order to evaluate the possibility of ADH3 involvement in NAE metabolism,
variable chain length NAEs were synthesized and evaluated as substrates for bovine liver
ADH3. NAEs were oxidized by ADH3 in the presence of NAD+, yielding the
corresponding N-acylglycinals. VMax/KM values for assayed NAEs were low relative to
cinnamyl alcohol, one of the preferred substrates for ADH3. Our data suggest that the
ADH-mediated oxidation of NAEs could occur in vivo, but that ADH3 is unlikely to be
the in vivo catalyst.
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Chapter I – Introduction

N-Acylethanolamines (NAEs)
N-Acylethanolamines (NAEs) belong to the class of fatty acid amides, which also
includes primary fatty acid amides (PFAMs), N-acyldopamines (NADAs), N-acylamides
(NAMs) and N-acylamino acids (NAAs) (1). They are the most widely studied group of
fatty acid amides and represent an important class of mammalian signaling molecules.
NAEs have been isolated from the brain as well as a variety of other tissues (1), and have
been associated with a number of important processes, such as appetite control,
regulation of energy metabolism, and anti-inflammatory response (1-3). NArachidonoylethanolamine (anandamide) is an endogenous ligand for cannabinoid
receptors (CB1 and CB2), and as a result, it is the most extensively studied of all NAEs.
Anandamide plays an important role in the stimulation of appetite, reduction of body
temperature and movement, and also has analgesic properties (1-4). It is thought that
most of these effects of anandamide are mediated by its binding to CB1 receptor.
Other long-chain NAEs whose functions have been established also play
important roles in the body. N-Palmitoylethanolamine is a well-known anti-inflammatory
agent, and also has analgesic properties (1, 2, 5). N-Oleoylethanolamine inhibits food
intake through binding to PPARα (peroxisome proliferator-activated receptor α) and
GPR119 (G-protein coupled receptor), thereby acting in opposition to anandamide (1, 3).
N-Stearoylethanolamine exhibits similar effects as anandamide with regard to analgesia,
body temperature and motility, although it is unable to bind to cannabinoid receptors (1).
It has also recently been found to possess anti-inflammatory properties (6). Long-chain
NAEs, including N-stearoylethanolamine and N-palmitoylethanolamine, have been
thought to simulate the effects of anandamide by acting as “entourage” compounds (7-8).
All long chain NAEs are degraded by fatty acid amide hydrolase (FAAH), and
“entourage” NAEs compete with anandamide for binding to FAAH, thereby effectively
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reducing its rate of degradation and prolonging its effects in the body. NAEs have also
been postulated to have a neuroprotective action, as their levels are increased in injured
neurons (4). Increase in NAE levels following cell stress and injury has also been found
in other organs, such as heart and testes, suggesting they may play a similar role in these
tissues as well (2).
Primary route for NAE synthesis is by the action of Nacylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD), which catalyzes
the cleavage of N-acylphosphatidylethanolamine (NAPE) into NAE and phosphatidic
acid (PA) (Fig. 1). NAE degradation to fatty acid and ethanolamine is accomplished
primarily through the action of fatty acid amide hydrolase (FAAH), although another
enzyme capable of doing the same chemistry, N-acylethanolamine-hydrolyzing acid
amidase (NAAA), has been discovered recently (9-10) (Fig. 2). Alternatively, it has been
proposed that NAEs could act as precursors in the biosynthetic pathway of PFAMs (1,
11), a related class of fatty acid amides (Fig 3).
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PFAMs were first identified in human plasma (12), but have since been isolated
from brain and cerebrospinal fluid as well. Like NAEs, they function as signaling and
regulatory molecules in the body. The best-studied PFAM is oleamide, which is
important in regulation of sleep, memory, body temperature and movement (1). Other
3

naturally occurring PFAMs include erucamide, linoleamide and elaidamide (1). Initially
proposed biosynthetic route to PFAMs was through reaction between fatty acid and
ammonia, catalyzed by FAAH (13). However, although this chemistry occurs in vitro, it
requires relatively high pH and high ammonia concentration, making it unlikely that it is
the primary synthetic pathway in vivo. There are two other possible routes to PFAM
biosynthesis. First route involves cytochrome c-catalyzed amidation of fatty acyl-CoA
thioester by ammonia (1, 14-15). The other route is by the action of peptidylglycine-αamidating monooxygenase (PAM) on N-acylglycines (NAG), resulting in production of
PFAMs and glyoxylate (Fig. 3). NAGs are well established as good substrates for PAM,
but their biosynthetic pathway is unclear. There is evidence that NAEs could serve as
precursors to NAGs through the sequential actions of a putative fatty alcohol
dehydrogenase (FADH) and a putative fatty aldehyde dehydrogenase (FALDH) (Fig. 3).
Support for this pathway comes from experiments in which 14C-labeled Narachidonoylglycine was detected in liver cells that were treated with 14C-labeled
anandamide (11). These experiments strongly suggest that there is a set of liver ADH and
ALDH enzymes capable of catalyzing the conversion of NAEs to NAGs.

Alcohol Dehydrogenases (ADHs)
Alcohol dehydrogenases (ADHs) comprise a family of NAD+-dependent, Zncontaining, dimeric enzymes responsible for oxidation of alcohols to aldehydes. ADH
dimers are composed of identical subunits, each containing two Zn ions, one of which
plays a structural role, and one which is involved in catalysis. Each subunit is composed
of two domains: a coenzyme binding domain, located close to the interface with other
subunit and a catalytic domain, located toward other ends of the dimer (Fig. 6). ADH
enzymes are divided into six classes based on their structure, substrate preference,
sensitivity to inhibitors, and electrophoretic mobility.
Class I ADH (ADH1) enzymes are expressed in all vertebrates, (16) and in
humans they are present in the liver, kidney, lung, mucosa of the stomach and lower
digestive tract (17). This class contains a number of isozymes, created through the
different combinations of three subunits designated as α, β, and γ. Among ADHs, ADH1

4

enzymes have lowest KM values (< 5mM) and highest kcat values for ethanol, indicating
that their primary role is metabolism of ethanol to acetaldehyde. They are also the most
strongly inhibited by 4-methylpyrazole, and have the highest isoelectric point of all ADH
enzymes (17). In addition to ethanol oxidation, ADH1 isozymes are also able to oxidize
retinol, and possess aldehyde dismutase activity, converting aldehydes to carboxylic acids
and alcohols (Fig. 4) (18).
Class II ADH (ADH2) is expressed exclusively in liver, and shares some of the
characteristics with ADH1. It has a higher KM and lower kcat value for ethanol than
ADH1, but it is likely also involved in ethanol metabolism. It is also inhibited by 4methylpyrazole, but to a smaller extent than ADH1, and it has a lower pI than class I
enzymes. Like ADH2, it is capable of utilizing retinol as a substrate, and it has been
shown to have aldehyde dismutase activity (18).

RCOOH

RCHO

E + NAD+

E-NAD+

E-NADH

ROH

E + NADH

RCHO

Figure 4. Aldehyde dismutation reaction.

Class IV ADH (ADH4) is found in the mucosa of the stomach and upper digestive
tract, and therefore may play a role in the first-pass metabolism of ethanol (19). It shares
many features with ADH2 – similar KM value for ethanol, similar pI, and similar level of
inhibition by 4-methylpyrazole. However, its turnover values for both ethanol and retinol
are higher, and it has been suggested that ADH4 is the primary enzyme for oxidation of
retinol to retinal (20-22).
Class V ADH (ADH5) has been characterized on cDNA and mRNA level in
humans (16, 23), but remains largely unstudied. Class VI (ADH6) has been isolated as
cDNA from deer mouse and rat (16, 20, 24), but has also not been investigated to greater
effect. The functions of these classes therefore remain largely unknown.
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Alcohol Dehydrogenase 3 (ADH3)
Class III alcohol dehydrogenase (ADH3) is found in virtually all eukaryotes and
prokaryotes and represents the ancestral enzyme from which all the other ADHs
originated. It was first isolated from human liver in 1981 (25), and it was fully
characterized in 1984 (26). Shortly thereafter, it was recognized that ADH3 is identical
to the previously characterized glutathione-dependent formaldehyde dehydrogenase (2728), which catalyzes the oxidation of S-(hydroxymethyl)-glutathione (HMGSH) (formed
through non-enzymatic conjugation of formaldehyde to glutathione (GSH)) (Fig. 5).
Together with S-formylglutathione hydrolase, ADH3 forms a major formaldehyde
detoxification pathway in the body (Fig 5).

Figure 5. Formaldehyde detoxification pathway.

Ethanol is a very poor substrate for ADH3, and saturation is never observed,
precluding the determination of KM and VMax values. Unlike all the other characterized
ADHs, ADH3 is not inhibited by 4-methylpyrazole, and cannot oxidize retinol. It also
lacks the aldehyde dismutase activity of ADH1 and ADH2 (18). Besides HMGSH, the
best substrates for ADH3 are medium- and long-chain alcohols (5 carbons and up), and
ω-hydroxy fatty acids, although it also able to oxidize 20-hydroxyleukotriene B4 (29).
This preference for larger substrates can be explained by the differences in the
active site size and structure between ADH3 and other ADH enzymes characterized to
date. In all ADH enzymes, active site is positioned in the cleft between the coenzyme
binding domain and the catalytic domain of the subunit (Fig. 6). In ADH1 and ADH4,
6

binding of the coenzyme induces a conformational change whereby catalytic unit rotates
by ~10o toward the coenzyme-binding domain, thereby converting the enzyme from the
“open” to the “closed” conformation (30-35). Closure of the active site enables tighter
binding for the smaller substrates, accounting for the preference these enzymes have for
shorter alcohols. Because NAD+ binding is required in order to achieve effective
substrate binding, these enzymes display an ordered bi-bi mechanism (31-32, 36).

Figure 6. ADH3 dimer (adapted from ref. 30). Subunits are colored blue and green. Coenzyme binding
domains are colored light blue and light green, and catalytic domains are dark blue and dark green.
Catalytic Zn ions are colored red, and structural Zn ions are shown in grey. Bound NAD+ molecules are
shown in purple. Yellow areas represent important secondary structures in the proximity of the active sites.

In contrast, the ADH3 active site displays a “semi-open” configuration that is inbetween the fully “open” and fully “closed” conformations exhibited by ADH1 (30-32).
In addition to this, coenzyme binding results in only small conformational changes
between the two domains, leaving a large, solvent-exposed active site approximately
twice the size of the ADH1 active site (30). Substrate binding is therefore not dependent
on prior NAD+ binding, and, as a result, ADH3 has a random bi-bi mechanism (36).
Having a large active site means that ADH3 is capable of accommodating bulky
substrates, like long chain alcohols, ω-hydroxy fatty acids and HMGSH. It also accounts
for its poor activity toward the smaller substrates, such as ethanol, which are unable to
form the bonding interactions they make in other ADHs. In addition to the open active
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site, smaller substrates lack the stabilization provided by the loop formed by residues 112
to 120 in ADH1, which is replaced by an α-helix in ADH3 which fails to provide any
binding support (30).
The well-established preference of ADH3 for large, hydrophobic alcohol
substrates suggests that it could act as the putative FADH, catalyzing the oxidation of
NAEs to N-acylglycinals. It is also the most ubiquitous of all the ADH enzymes, and it is
the sole ADH representative so far characterized in the brain (37), where abundance of
NAEs is found. Its substrate preference combined with its presence in the tissues where
NAEs have been found, led us to investigate ADH3 as a potential FADH, acting in the
first step of the proposed PFAM biosynthetic pathway to catalyze the oxidation of NAEs
to N-acylglycinals (Fig. 3).

8

Chapter 2 – Materials and Methods

Enzyme Purification
Bovine liver ADH3 was purified following the modified procedure of
Pourmotabbed et al. (38). Purification was accomplished by performing ammonium
sulfate precipitation, followed by DEAE-cellulose, mimetic blue II, and blue dextran
agarose chromatography.
A. Ammonium Sulfate Precipitation
Fresh bovine liver was obtained from Central Packing Co Inc, (Center Hill, FL),
cut into parts, and frozen at – 80 oC. Bovine liver portion weighing 265 g was thawed out,
chopped into small pieces, combined with 795 ml of 50 mM potassium phosphate pH 7.5,
5 mM β-mercaptoethanol (BME), and a cocktail of protase inhibitors (1µg/ml leupeptin,
1 µg/ml pepstatin A, and 1 µg/ml aprotinin), and blended for 3 x 30 seconds in a Waring
blender at high setting. Blended mixture was centrifuged in a Sorvall RC 6 centrifuge at
20,000 x g and 4 oC for 40 minutes. Pellet was then discarded and supernatant
centrifuged at 32,000 x g and 4 oC for 30 minutes. Reddish-brown supernatant (670 ml)
was obtained following the second centrifugation, and taken to 45% saturation by
addition of 173 g of ammonium sulfate. Finely ground ammonium sulfate was added
slowly over a 1-hour period with continuous stirring, and pH of the solution was
maintained at 7.4 by addition of concentrated NH4OH. Following salt addition, solution
was left to equilibrate for 2 hours without stirring. Equilibrated solution was centrifuged
at 47,800 x g for 30 minutes. Recovered supernatant (600 ml) was then taken to 67%
saturation by addition of 84 g of ammonium sulfate. As previously, ammonium sulfate
was added slowly over 1 hour and pH was maintained by addition of concentrated
NH4OH. Following equilibration, solution was centrifuged at 47,800 x g for 30 minutes.
Supernatant was discarded and pellet dissolved in minimum amount of 10 mM Tris pH
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7.6 and 5 mM BME solution. Sample was then dialyzed in the same buffer in order to
remove the salt.
B. DEAE-Cellulose Chromatography
Following dialysis, sample was loaded onto a DEAE cellulose column (2 x 40
cm) previously equilibrated with 10 mM Tris pH 7.6 and 5 mM BME. Column was
washed with running buffer until A280 was reduced to 0.2, and eluent was collected in 15
ml fractions. ADH3 was eluted off the column by running a linear pH gradient with 500
ml of running buffer (10 mM Tris pH 7.6) and 500 ml of 10 mM Tris pH 7.0. Fractions
were assayed for protein content by measuring absorbance at 280 nm, while enzyme
activity was assayed by following NADH production using cinnamyl alcohol as substrate.
Fractions with highest specific activity were pooled together and dialyzed into solution of
10 mM Tris pH 8.0 and 2 mM dithiothreitol (DTT).
C. Mimetic Blue II Chromatography
Dialyzed sample was loaded onto a Mimetic Blue II affinity column (1.5 x 20 cm)
that was previously equilibrated with 10 mM Tris pH 8.0 and 2 mM DTT. Column was
washed with the same buffer and flow rate was adjusted to 1 ml/min. Eluent was
collected in 4 ml fractions. Protein content was monitored by measuring absorbance of
fractions at 280 nm. Once A280 was below 0.2, a linear gradient of 0-20 mM NAD+ (total
volume 200 ml) was applied to the column in order to elute ADH3. Fractions were
assayed for enzyme activity by following NADH production at 340 nm, with cinnamyl
alcohol as substrate. Fractions with highest specific activity were pooled together and
dialyzed into 0.5 mM Tris pH 7.0 and 5 mM BME.
D. Blue Dextran Agarose Chromatography
Following dialysis to remove NAD+, sample was loaded onto a Blue Dextran
agarose column (5 ml), that had been equilibrated with 0.5 mM Tris pH 7.0 and 5 mM
BME. Column was washed with the same buffer and the eluent was collected in 3 ml
fractions, which were assayed for protein content and enzymatic activity as described
before. Fractions with the highest specific activity were analyzed for purity using SDS-

10

PAGE, and those containing only a single protein band corresponding to the weight of an
ADH3 subunit (~40 kDa) were pooled together. Protein concentration of purified ADH3
was determined using the Bradford assay, and concentrated enzyme was stored at -80 oC.
E. Enzyme Activity Assay
Enzyme activity was evaluated by following NADH production at 340 nm, with
cinnamyl alcohol as the substrate. Assays were done in 100 mM glycine pH 10, 5 mM
cinnamyl alcohol, and 2.5 mM NAD+ at 37 oC. NADH production was followed at 340
nm using JASCO V-530 UV-Vis spectrophotometer. When scanning crude enzyme
fractions, which are know to include ADH1 and ADH2, assay also included 3 mM
pyrazole, a know inhibitor of these two enzymes. In addition to this, rates for controls
without the substrate were obtained and subtracted from the reaction rates in order to
eliminate false positives.

Syntheses
A. Synthesis of NAEs
A number of N-acylethanolamines were available commercially in high purity and
these were obtained and used without further purification. N-Arachidonoylethanolamine
and N-linoleoylethanolamine were purchased from Cayman Chemical Company, Nacetylethanloamine was obtained form Sigma-Aldrich, and N-propionylethanolamine was
purchased from TCI.
The remaining N-acylethanolamines were synthesized as described in Jonsson et
al. (7-8) (Scheme 1). Briefly, an excess of ethanolamine (~ tenfold) was added to 15-20
ml of anhydrous CH2Cl2 and placed in an ice-bath. Acyl chloride (0.012 moles) was
added drop-wise to the solution while stirring and under N2. Upon complete addition of
the chloride, reaction mixture was removed from ice and left stirring at room temperature
for another 12 hours. Mid- and long-chain NAEs (octanoyl and longer) were purified by
recrystallization in ethanol/water. Short-chain NAEs (butyryl, hexanoyl and benzoyl)
were purified using a silica column run in ethyl acetate: methanol (80:20). The yields for
the synthesized NAEs were as follows: N-butyrylethanolamine – 48.3 %, N-
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hexanoylethanolamine – 20.6 %, N-benzoylethanolamine – 28.2 %, Noctanoylethanolamine – 44.5 %, N-decanoylethanolamine – 77.4 %, Nlauroylethanolamine – 77.6 %, N-myristoylethanolamine – 73.4 %, N-oleoylethanolamine
– 84.5 %. Purity and identity of synthesized NAEs were confirmed by 1H and 13C NMR
on iNOVA 400 MHz (see Figures A1-A8). All acyl chlorides and ethanolamine were
obtained from Sigma-Aldrich, and used without further purification. Anhydrous CH2Cl2
was purchased from EMD.

O

O

+
R

OH
H2N

N2, CH2Cl 2 (anhyd.)
12 hours

Cl

OH
R

N
H

Scheme 1. Synthesis of NAEs.

B. Synthesis of [1’,2’-13C]- N-Octanoylethanolamine
Uniformly 13C-labeled ethanolamine HCl was dissolved in CH3CN and a 10-fold
molar excess of triethylamine (TEA) under N2. One equivalent of octanoyl chloride was
added drop-wise, and the reaction mixture was left to stir at room temperature for 12
hours (Scheme 2). Reaction progress was monitored by TLC (ethyl acetate: methanol
(80:20 (v/v))). Once reaction was > 90% complete, solvent was removed, and residue
was redissolved in the same mobile phase used for TLC. [1’,2’-13C] -NOctanoylethanolamine was purified by silica column chromatography in 53 % yield, and
characterized by 1H and 13C NMR spectra obtained on the Varian iNOVA 400 (Fig. A-9).

Scheme 2. Synthesis of [1’,2’-13C]- N-Octanoylethanolamine. 13C labeled atoms are marked by *.
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C. Synthesis of N-Acylglycinals
N-Benzoylglycinal and N-octanoylglycinal were prepared using the modified
procedure of Brown (39) (Scheme 3). Aminoacetaldehyde diethyl acetal (50 mmoles)
was dissolved in 75 ml of diethyl ether and placed in an ice-bath. Next, one equivalent (5
ml of 15 M) KOH was added to the solution. One equivalent of acyl chloride and another
two equivalents of KOH were simultaneously added drop-wise to the reaction mixture.
Once addition was complete, reaction was left stirring on ice for another 3 hours.
Reaction progress was monitored by TLC (hexanes: ethyl acetate (1:1)). Ether and
aqueous layers were separated, and ether layer was washed with 5 x 30 ml of saturated
NaCl, and dried with MgSO4. Solvent was removed under vacuum to obtain Nacylglycinal diethyl acetal. Product purity and identity were confirmed by 1H and 13C
NMR on Burker DPX 250.
N-Benzoylglycinal and N-octanoylglycinal were obtained by acid-catalyzed
deprotection of the corresponding N-acylglycinal diethyl acetals. N-acylglycinal diethyl
acetal was dissolved in 25 ml of diethyl ether, 10 ml of saturated NaCl, 7 ml of deionized
H2O, and 3 ml of concentrated HCl. Reaction mixture was left stirring for 12 hours, and
reaction progress was monitored by TLC (CH2Cl2: EtOAc (80:20)). Organic layer was
separated and dried with MgSO4. Solvent was removed under vacuum and the residue
was dissolved in CH2Cl2: EtOAc (80:20), and applied to a silica column (5 x 20 cm). NBenzoylglycinal and N-octanoylglycinal were obtained in 9 %, and 11 % yields,
respectively. Purity and identity of both compounds were confirmed by 1H and 13C NMR
spectra obtained on Varian iNova 400 MHz (Figs A-10-11).
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Scheme 3. Synthesis of N-Acylglycinals.

D. Synthesis of N-Octanoylglycine
N-Octanoylglycine was synthesized following the modified procedure of Iyer et
al. (40). Glycine (0.02 mol) was dissolved in 100 ml of deionized water, and pH was
adjusted to 10 by addition of 2 M NaOH. One equivalent of octanoyl chloride was added
drop-wise to the solution, while maintaining pH 10 with addition of 2 M NaOH.
Following 1.5 hours of reaction time, solution was acidified to pH 1 by addition of 30%
H2SO4. White precipitate formed following acidification, and was filtered off and dried.
Precipitate was then recrystallized with EtOAc/petroleum ether to obtain the pure product
14

in 49% yield. N-Octanoylglycine identity and purity was confirmed by 1H and 13C NMR
on Varian iNOVA 400 (Fig A-13).
E. Preparation of N-Octanoylglycinal semicarbazone
N-Octanoylglycinal semicarbazone standard was prepared by reacting Noctanoylglycinal with a large excess (~10 fold) of semicarbazide in aqueous solution. NOctanoylglycinal semicarbazone was purified using HPLC and characterized by 1H and
13

C NMR on Varian iNova 400 (Fig A-12).

Kinetic Assays of NAE Substrate Activity with ADH3
A. Spectrophotometric NADH Assay
Kinetic constants for short and mid-length NAEs were determined from initial
reaction rates obtained by following NADH production at 340 nm. Reaction conditions
were as follows: 100 mM glycine pH 10, 2.5 mM NAD+, and 15-30 µg/ml ADH3 in 1 ml
total reaction volume. NAE concentrations were between 0.1KM and 10KM. Enzyme
assays were conducted at 37 oC, using JASCO V-530 UV-Vis spectrophotometer.
Glycine was purchased from J.T. Baker, sodium pyrophosphate was obtained from
Fisher, and NAD+ was acquired from Bioworld. All were used without further
purification. Rates were normalized using rate for 250 µM cinnamyl alcohol as the
standard.
B. MTS-Formazan Assay
Due to the low solubility of long chain NAEs full kinetic assays to determine their
kinetic constants could not be performed. As the compounds could only be assayed at
relatively low concentrations (<100 µM), the rates of NADH production were very low
and could not be confidently determined using the spectrophotometric NADH assay.
Instead, a more sensitive method for NADH detection was employed, coupling the
NADH production to the reduction of a tetrazolium dye MTS ([3-(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) to the
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colored formazan with λmax at 490 nm and ε = 20,800 M-1cm-1 at pH 9.5 (Fig. 7). PMS
(phenazinemethosulfate) was used as an intermediate electron carrier.

Figure 7. MTS-formazan assay for NADH detection.

NAEs with 10 or more carbon atoms in the chain were all assayed for ADH3
activity at the same concentration employing the MTS-formazan assay. The assay
conditions were as follows: 100 mM sodium pyrophosphate pH 9.5, 55 µM NAE, 2.5
mM NAD+, 150 µM MTS, 8.25 µM PMS, 3 % DMSO and 30 µg/ml ADH3. Decanoyl
and lauroylethanolamine were soluble enough to allow the determination of KM and VMax
values as well. All reactions were done at 37 oC and the initial rates were determined by
observing the increase in absorbance at 490 nm using JASCO V-530 UV-Vis
spectrophotometer. MTS was purchased from Promega and PMS was obtained from TCI
America. Rates for cinnamyl alcohol obtained in this manner matched the rates obtained
by following NADH production at 340 nm. Rates were normalized using rate for 250 µM
cinnamyl alcohol as the standard.

Modeling Experiments
The crystal structure of human ADH3 (PDB ID 1MP0 (41)) was used for gridbased ligand docking. All co-crystallized ligands deemed superfluous for enzyme
function were removed from the crystal structure and polar hydrogens were added using
AutoDockTools. Charges were then corrected for the requisite zinc ions and bond orders
corrected for the co-substrate, NAD+. The receptor grid was prepared with a grid point
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spacing of 0.2 Å using AutoGrid. The substrates of interest were then prepared using
AutoDockTools to define torsions, rotamers, and polar hydrogens. The ligands were then
docked into the active site of ADH using AutoDock 4.0 (42-43). All default settings
were utilized with the exception of increasing the number of energy evaluations from 2.5
x 104 to 2.5 x 107.

Product Characterization Experiments
A. HPLC Separation Experiments
Experiments were performed on a HP 1100 Agilent, equipped with a 4-channel
solvent mixing system, a quaternary pump, and a deuterium lamp UV detector. All
separations were accomplished using a Thermo-Scientific C18 column (4.6 x 250 mm),
with temperature regulated at 40 oC. N-Benzoylethanolamine and its derivatives were
separated using either a gradient of 50 mM sodium phosphate pH 6.0: CH3CN - 90: 10 to
95:5 over 20 minutes, or isocratic mobile phase of 50 mM sodium phosphate pH 6.0:
CH3CN (90:10 (v/v)) (Fig. B-1). Compounds were detected by following UV absorbance
at 230 nm.
Cinnamyl alcohol and its derivatives were separated using gradient of 50 mM
sodium phosphate pH 6.0: CH3CN – 75:25 to 40:60 over 15 minutes, and compounds
were detected by monitoring absorbance at 265 nm (Fig B-2).
N-Octanoylglycinal semicarbazone and semicarbazide were separated using
gradient of H2O: CH3CN - 70:30 to 40:60 over 20 minutes (Fig B-3). The compounds
were detected by monitoring absorbance at 210 nm.
B. GC-MS Experiments
GC-MS experiments were performed on Shimadzu GC-MS instrument equipped
with a DB-5 (0.25 µm x 0.25 mm x 30 m) column. Compounds were extracted from
reaction mixture using either ethyl ether (cinnamyl alcohol and cinnamyl aldehyde) or
CH2Cl2 (N-benzoylethanolamine and its derivatives). Reaction mixture was acidified
prior to N-benzoylglycine extraction. Solvent was removed and samples were derivatized
prior to analysis in order to increase their volatility and signal strength. Aldehyde
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derivatization to PFB-oximes was done by dissolving the extracted and dried residue into
90 µl of CH3CN, adding 10 µl of 100 mM PFBHA (O-(2,3,4,5,6pentafluorobenzyl)hydroxylamine), and heating the solution at 60 oC for 60 minutes
(Scheme 4).

Scheme 4. PFBHA derivatization reaction.

N-Benzoylglycine derivatization was done by dissolving the extracted and dried
material in 100 µl of BSTFA (N,O-bis(trimethylsilyl)trifluoroacetamide), purging the
solution with N2, and heating it at 90 oC for 15-20 minutes (Scheme 5). Carboxylic group
and amide moiety of NAGs can be both be derivatized by this method, as can hydroxyl
and amide groups of NAEs.

Scheme 5. BSTFA derivatization reaction.
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Derivatized samples (5-10 µl) were injected into the GC-MS in a splitless manner,
with injection temperature at 250 oC. Temperature program was modified from Merkler
et al. (44). Oven temperature was raised from 55.0 oC to 150.0 oC, at a rate of 40.0
o

C/min, held at 150.0 oC for 3.6 min, then raised to 300 oC at a rate of 10.0 oC/min, and

finally held at 300 oC for 1.0 min. Interface temperature between GC and MS was 280
o

C, and solvent cut time was 7-9 min. For N-benzoylglycinal detection, injection volume

was increased to 40 µl in order to more confidently detect the TMS-benzoylglycine
derivative. Solvent cut time was raised to 11.5 min, so as to avoid column overload by
the far more concentrated di- and mono-TMS-N-benzoylethanolamine derivatives eluting
at 10.7 and 11.2 min, respectively. Peak identity was established by comparison of
retention times and mass spectra with those of derivatized standards and library spectra.
C. Trapping N-acylglycinals with semicarbazide
In order to characterize the reaction products, N-acylglycinals, which are unstable
at reaction pH, semicarbazide was employed as an aldehyde-trapping reagent.
Semicarbazide was added in large excess (9-10 x substrate concentration) to the reaction
mix containing 100 mM sodium pyrophosphate pH 9.5, 3-5 mM N-benzoylethanolamine,
2.5 mM NAD+, and 0.25-1.0 mg/ml ADH3. Formation of N-benzoylglycinal
semicarbazone was followed by HPLC.
D. N-Acylglycinal Semicarbazone Characterization by 13C NMR
N-Octanoylglycinal semicarbazone was characterized by following the enzymatic
oxidation of [1’,2’-13C]-N-octanoylethanolamine in the presence of semicarbazide by 13C
NMR. The presence of N-octanoylglycinal semicarbazone was established by observing
the reduction in intensity of the 13C labeled signals in the substrate and the appearance of
two 13C carbon signals consistent with those of N-octanoylglycinal semicarbazone. Peak
identity was confirmed by comparison with 13C spectrum of synthesized Noctanoylglycinal semicarbazone (Fig. A-12). Reaction conditions were as follows: 50
mM sodium pyrophosphate pH 8.0, 2.5 mM [1’,2’-13C]-N-octanoylethanolamine, 2.5 mM
NAD+, 20 mM semicarbazide HCl, 10% D2O, and 1.7 mg/ml ADH3. Reaction mix was
incubated at 37 oC, and 13C NMR spectra were taken after 24 hour and 48 hour reaction
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time points. Control samples containing all the reagents except for the enzyme were
handled and analyzed in the same manner. Experiments were performed on a Varian
iNova 400 MHz instrument.
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Chapter 3 – Results and Discussion

ADH3 Purification
ADH3 was purified from bovine liver to ~ 90 % homogeneity (Fig. 8), and stored
at -80 oC for later use in enzymatic assays. Specific activity of purified ADH3 was 0.53
U/mg, which is somewhat lower that the previously reported values of ~ 3.0 U/mg (38).
Relatively low activity is most likely due to the fact that enzyme was purified from liver
that had been stored in the freezer for several months, rather than a fresh sample.
Molecular weight of ADH3 subunits, calculated based on the Rf values determined from
the SDS-PAGE was 38 kDa, which is in good agreement with previously determined
values of 40-41 kDa (32).
MWL

ADH3 ADH3 MWL
250 kDa
150 kDa
100 kDa
75 kDa

50 kDa

37 kDa

25 kDa
Figure 8. SDS-PAGE of purified bovine liver ADH3. The outer two lanes contain the Kaleidascope
molecular weight ladder (MWL), and the inner lanes contain purified ADH3.
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Kinetics of ADH3-catalyzed NAE Oxidation
A variety of aliphatic NAEs with chain lengths varying from 2 to 20 carbons, as
well as several aromatic NAEs were evaluated as substrates for ADH3, in the manner
described previously (Fig. 9). All of the tested NAEs were found to be substrates for
ADH3, with KM values decreasing with increase in chain length of the acyl substituent
(Table 1). This indicated that increase in substrate size led to tighter binding to the
enzyme, or rather that small size impaired the ability to bind to the site tightly, which was
in agreement with known substrate preferences of ADH3 (26) and previous
crystallographic studies of the enzyme active site (30-32). VMax followed the same trend,
decreasing with increase in substrate size and hydrophobicity. However, decrease in KM
was more dramatic, resulting in overall increase in VMax/KM values with increase in
substrate chain length (see Table 1). These findings are in agreement with the previous
studies, which established the preference of ADH3 for bulky, longer chain alcohol
substrates, in contrast with other ADH enzymes (26). While ADH3 could catalyze the
oxidation of all tested NAEs, their turnover values were low compared to cinnamyl
alcohol, one of the preferred ADH3 substrates (see Tables 1 and 3).
Michaelis-Menten plot of ADH3-catalyzed N-hexanoylethanolamine oxidation
1.6
1.4

Rate (µmol/min/mg)

1.2
1.0
0.8
0.6
0.4
VMAX = 1.6 +/- 0.018 µmol/min/mg
KM = 9.5 +/- 0.36 mM

0.2
0.0
0

20

40

60

80

100

120

[N-Hexanoylethanolamine] (mM)

Figure 9. A representiative Michaelis-Menten plot for one of the assayed NAEs.
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Table 1. Kinetic constants for short- and medium-chain NAEs.
O

Substrate

KM

VMax

(mM)

(µmol/min/mg)

(4.5 ± 0.35) x 102

1.9 ± 0.059

0.0041

OH
R

N
H

VMax / KM

N-acetylethanolamine

R = CH3

N-propionylethanolamine

R = CH3CH2

79 ± 3.8

1.9 ± 0.026

0.024

N-butyrylethanolamine

R = CH3(CH2)2

46 ± 5.4

1.7 ± 0.052

0.038

N-hexanoylethanolamine

R = CH3(CH2)4

9.5 ± 0.36

1.6 ± 0.018

0.17

N-octanoylethanolamine

R = CH3(CH2)6

5.8 ± 0.38

1.5 ± 0.028

0.26

N-decanoylethanolamine

R = CH3(CH2)8

0.32 ± 0.029

0.57 ± 0.024

1.8

N-lauroylethanolamine

R = CH3(CH2)10

0.033 ± 0.0061

0.14 ± 0.0088

4.3

Kinetic constants could not be determined for NAEs longer than lauroyl due to
very low solubility and low reaction rates. Table 2 shows a comparison of rates for two
medium-chain (decanoyl and lauroyl) and several long chain NAEs at a single substrate
concentration. Rates continue to follow a decreasing trend observed with short and
medium chain NAEs, with the exception of myristoylethanolamine which has a
significantly lower rate compared to the longer NAEs tested. It is possible that this result
is related to the unsaturated bonds present in other higher length NAEs, which may
enable tighter binding to the enzyme.
Table 2. Relative ADH3 rates for medium and long-chain NAEs
O

Relative

Substrate

OH
R

Rates

N
H

N-decanoylethanolamine

R = CH3(CH2)8

1.0

N-lauroylethanolamine

R = CH3(CH2)10

0.57

N-myristoylethanolamine

R = CH3(CH2)12

0.061

N-oleoylethanolamine

R = CH3(CH2)7HC=CH(CH)7

0.28

N-linoleoylethanolamine

R = CH3(CH2)7HC=CHCH2HC=CH(CH)4

0.26

N-arachidonoylethanolamine

R = CH3(CH2)3HC=CHCH2HC=CHCH2HC=CHCH2HC=CH(CH)4

0.24

Among the NAEs with an aromatic substituent, compounds with benzyl group
had lower KM values, higher VMax values, and therefore higher turnover values compared
to compounds with a phenyl substituent (see Table 3), indicating that the presence of CH2
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group following the aromatic ring might have contributed to better binding and more
efficient catalysis.

Table 3. Kinetic constants for aromatic NAEs and cinnamyl alcohol.
O

Substrate

KM

VMax

(mM)

(µmol/min/mg)

OH
R

N
H

VMax / KM

N-benzoylethanolamine

R = C6H6

5.2 ± 0.52

0.36 ± 0.0098

0.069

N-phenylacetylethanolamine

R = C6H6CH2

3.9 ± 0.24

1.2 ± 0.026

0.32

N-benzyloxycarbonylethanolamine

R = C6H5CH2O

2.3 ± 0.14

0.81 ± 0.014

0.36

N-(2-Phenoxyacetyl)ethanolamine

R = C6H5OCH2

6.3 ± 0.36

0.25 ± 0.0042

0.040

Cinnamyl alcohol

C6H6HC=CHCH2OH

0.035 ± 0.0033

4.0 ± 0.058

4.1 × 102

Docking Experiments
NAEs with chain length between 2 and 11 carbons were docked into the human
ADH3 crystal structure using AutoDock 4.0 in order to evaluate their relative binding
energies (Table 4). Sequence alignment of human and bovine ADH3 using BLAST (4546) shows that they share 94% identity, with 98 % of residues conserved, making the
docking results obtained with the human enzyme applicable to bovine ADH3 as well.
Relative binding energies of docked NAEs were found to follow the same general trend
as KM values, decreasing with increase in chain length (Table 4), indicating that tighter
binding to the enzyme is at least partly responsible for the observed KM trend. These
findings provide further agreement with previously determined substrate preference (26)
and crystallographic data (30-32). Substrates were docked in the enzyme active site with
hydroxyl group coordinating with the catalytic Zn ion (Fig. 7), in the same manner as
other ADH3 substrates have been shown to bind (31-32).
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Table 4. Relative binding energies and KM values for selected NAEs and cinnamyl alcohol. Binding
energies values were calculated using Autodock 4.0, and have a standard error of about ± 2.5 kcal/mol (43).
Substrate

KM (mM)

Estimated free energy of binding (kcal/mol)
2

(4.5 ± 0.35) x 10

-3.72

N-propionylethanolamine

79 ± 3.8

-4.14

N-butyrlethanolamine

46 ± 5.4

-4.22

N-hexanoylethanolamine

9.5 ± 0.36

-4.34

N-octanoylethanolamine

5.8 ± 0.38

-4.31

N-decanoylethanolamine

0.32 ± 0.029

-4.34

N-lauroylethanolamine

0.033 ± 0.0061

-4.06

N-benzoylethanolamine

5.2 ± 0.52

-4.58

0.035 ± 0.0033

-4.68

N-acetylethanolamine

Cinnamyl alcohol

Figure 10. N-Hexanoylethanolamine docked into the active site of human ADH3 (PDB ID 1MP0).
Protein backbone is shown in green, Zn ions are gray spheres, and NAD+ and N-hexanoylethanolamine are
shown as stick models with CPK-colored atoms.
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Product Characterization
Characterization of the product of the enzymatic reaction was initially attempted
by following the reaction progress by HPLC. HPLC analysis of the ADH3-catalyzed Nbenzoylethanolamine oxidation revealed the presence of a peak consistent with Nbenzoylglycine as well as a peak corresponding to N-benzoylglycinal (Fig. 11). NBenzoylglycine and N-benzoylglycinal are the two possible products of the enzymatic
oxidation of N-benzoylethanolamine. However, ADH3 has not been found to catalyze the
dismutation of aldehydes (18). Experiments using N-benzoylglycinal as a substrate for
ADH3 indicated that ADH3 is not able to catalyze the oxidation of N-benzoylglycinal,
but that N-benzoylglycinal can undergo non-enzymatic dismutation to N-benzoylglycine
and N-benzoylethanolamine under the employed reaction conditions (2.5 mM NAD+, pH
9.5-10). HPLC analysis of ADH3-catalyzed cinnamyl alcohol oxidation revealed only
peak consistent with cinnamyl aldehyde (Fig. 12), further suggesting that the reaction
products of NAE oxidation are N-acylglycinals, and that any NAGs observed are
produced through non-enzymatic means.

N-benzoylethanolamine

NAD+/NADH

NAD+ derivative
N-benzoylglycine
N-benzoylglycinal

Figure 11. HPLC separation of ADH3-catalyzed N-benzoylethanolamine oxidation. Reaction
conditions were as follows: 100 mM sodium pyrophosphate pH 9.5, 2.5 mM NAD+, 6 mM Nbenzoylethanolamine, and 2.4 mg/ml ADH3. An aliquot was taken for HPLC analysis after 36 hours of
reaction time. Peak at 3.918 was determined to be NAD+ derivative formed during prolonged incubation at
high pH and was also observed in the control sample containing only NAD+ and buffer.

26

NAD+/NADH

cinnamyl
alcohol

cinnamyl
aldehyde

Figure 12. HPLC separation of ADH3-catalyzed cinnamyl alcohol oxidation. Reaction conditions were
as follows: 100 mM sodium pyrophosphate pH 9.5, 2.5 mM NAD+, 1.75 mM cinnamyl alcohol, and 5
µg/ml ADH3. HPLC analysis was performed after 45 minutes of reaction time.

Further characterization of the product peaks observed by HPLC was conducted
using GC-MS. In order to test the validity of the method, the procedure was first used to
characterize cinnamyl alcohol reaction product. Derivatization of cinnamyl alcohol
reaction extract with PFBHA gave two peaks detected by GC-MS, whose retention times
and fragmentation patterns were consistent with those for two isomers of cinnamyl
aldehyde PFB-oxime (Fig. 13), thus confirming that the reaction product is cinnamyl
aldehyde. However, applying the same method to characterize N-benzoylglycinal
observed by HPLC proved unsuccessful. Although derivatized standard for Nbenzoylglycinal-PFB-oxime was successfully characterized using GC-MS (Fig C-3), the
compound could not be detected by this method in the reaction extracts. This can be
attributed to the very low turnover rates of N-benzoylethanolamine oxidation compared
to cinnamyl alcohol oxidation (Table 3), as well as to the tendency of N-benzoylglycinal
to undergo oxidation to N-benzoylglycine under the reaction conditions. Derivatizing
reaction extract with BSTFA resulted in detection of N,O-di-TMS-N-benzoylglycine
(Fig. 14), thus confirming that the peak observed by HPLC is N-benzoylglycine.
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Cinnamyl aldehyde O-PFB-oximes
(Z and E isomers)

77

91

130
F
N

181
F

O

F

F
F

(1E,2E)-cinnamaldehyde O-perfluorobenzyl oxime
Chemical Formula: C16H 10F5NO
Exact Mass: 327.07

Figure 13. GC-MS spectra of cinnamyl aldehyde O-PFB-oximes. Cinnamyl aldehyde PFB-oximes were
detected through GC-MS analysis of cinnamyl alcohol reaction extract that was treated with PFBHA. The
two peaks correspond to the two cinnamyl aldehyde O-PFB-oxime isomers (E and Z), which differ in
retention times, but have identical fragmentation patterns. See Fig. C-1 for cinnamyl aldehyde O-PFBoxime standard spectra.
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N,O-di-TMS-N-benzoylglycine

105
O

308

206

73

45

77

O
N

73 Si

Si
O

N,O-di-TMS-N -benzoylglycine
Chemical Formula: C15H25NO3Si2
Exact Mass: 323.14

Figure 14. GC-MS spectrum of N,O-di-TMS-N-benzoylglycine. N,O-di-TMS-N-benzoylglycine peak
was detected in derivatized extract of ADH3-catalyzed N-benzoylethanolamine reaction. Extraction and
GC-MS analysis were performed after 24 hours of reaction time.

In order to detect and characterize the unstable N-acylglycinal product, a wellknown aldehyde-trapping reagent, semicarbazide, was added to the reaction mixture.
Semicarbazide readily reacts with aldehydes and ketones to form semicarbazones (Fig.
15). HPLC analysis of N-benzoylethanolamine reaction containing semicarbazide
revealed a peak consistent with the peak for N-benzoylglycinal semicarbazone standard
(Figs.12 and B-1). Further characterization of the semicarbazone derivative was
attempted by LC-MS and GC-MS, but proved unsuccessful.
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O
O

O

+
R1

R1
N
H

R2

N

H 2N

N
H

NH2

NH2

R2

Aldehyde/Ketone

Semicarbazone

Semicarbazide

Figure 15. Semicarbazone formation reaction.

NAD+/NADH

N-benzoylethanolamine

N-benzoylglycinal
semicarbazone
NAD+ derivative

Figure 16. HPLC analysis of ADH3-catalyzed N-benzoylethanolamine oxidation in the presence of
semicarbazide. Reaction conditions were as follows: 100 mM sodium pyrophosphate pH 9.5, 2.5 mM
NAD+, 4 mM N-benzoylethanolamine and 300 µg/ml ADH3. HPLC analysis was performed after 24 hours
of reaction time.

In order to characterize the putative N-acylglycinal semicarbazone species
detected by HPLC, reaction was analyzed by 13C NMR. For the purpose of increased
sensitivity, [1’,2’-13C]-N-octanoylethanolamine was synthesized and employed as the
reaction substrate. Analysis of [1’,2’-13C]-N-octanoylethanolamine reaction showed a
total of 4 different 13C signals – two that matched those for the substrate, at 41 and 60
ppm (Fig. A-9), and two new 13C signals, at 40 and 143 ppm. Chemical shifts of the two
new signals match those of the corresponding carbon atoms in the N-octanoylglycinal
semicarbazone standard (Figs. 17 and A-12), thus providing confirmation that the product
of the ADH3 catalyzed oxidation is N-acylglycinal, in agreement with previously
published data (18). Performing the reaction in absence of semicarbazide resulted in
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appearance of 13C signals consistent with those of N-octanoylglycine (Figs. 18 and A-13).
This result was consistent with previous HPLC experiments, which showed that Nbenzoylglycinal is readily oxidized to N-benzoylglycine at basic pH. Control sample with
no ADH3 present showed only the two substrate peaks (Fig A-14), confirming there was
no detectable oxidation of N-octanoylethanolamine through non-enzymatic means.

B

A

B2

A2

Figure 17. 13C NMR spectrum of ADH3-catalyzed [1’,2’-13C]-N-octanoylethanolamine oxidation in
the presence of semicarbazide. Reaction conditions were as indicated in Chapter 2, and spectrum was
taken after 48 hours of reaction time.
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B

A

A3
B3

Figure 18. 13C NMR spectrum of ADH3-catalyzed [1’,2’-13C]-N-octanoylethanolamine oxidation
without semicarbazide. Reaction conditions were as indicated in Chapter 2 with the exception of
semicarbazide, which was omitted. Spectrum was taken after 48 hours of reaction time.

Conclusion
Evaluation of NAEs as ADH3 substrates showed that they can be oxidized by this
enzyme, which is known to act on a variety of mid- and long-chain alcohol substrates. In
accordance with previous literature reports, the reaction products were shown to be Nacylglycinals, which ADH3 was unable to oxidize further to NAGs. Relatively low
conversion rates observed for ADH3-catalyzed NAE oxidation make it unlikely that
ADH3 plays a significant role in conversion of NAEs to N-acylglycinals in vivo.
Nevertheless, our findings validate the chemistry proposed in the pathway, and further
suggest that another ADH enzyme could be responsible for the oxidative degradation of
NAEs. Further studies on ADH5 and ADH6 should be completed in order to evaluate the
possibility of their involvement in NAE metabolism, as these two enzymes have as of yet
been poorly investigated and could potentially play the role of FADH in the conversion
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of NAEs to NAGs. Additionally, NAEs could be evaluated as substrates or inhibitors of
other ADH enzymes, in order to explore their potential role in alcohol or retinol
metabolism.
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Appendix A – NMR Spectra

Figure A-1. 1H and 13C NMR Spectra of N-Butyrylethanolamine in DMSO-d6. Peak at 3.409 ppm in
the 1H spectrum is due to presence of a small amount of H2O in the solvent.

40

Appendix A (Continued)
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OH
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H

N -Hexanoylethanolamine

Figure A-2. 1H and 13C NMR Spectra of N-Hexanoylethanolamine in DMSO-d6.
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Appendix A (Continued)
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N -Octanoylethanolamine

Figure A-3. 1H and 13C NMR Spectra of N-Octanoylethanolamine in DMSO-d6.
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Appendix A (Continued)

Figure A-4. 1H and 13C NMR Spectra of N-Decanoylethanolamine in DMSO-d6.
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Appendix A (Continued)

Figure A-5. 1H and 13C NMR Spectra of N-Lauroylethanolamine in DMSO-d6.
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Appendix A (Continued)

Figure A-6. 1H and 13C NMR Spectra of N-Myristoylethanolamine in DMSO-d6. Peak at 3.280 ppm in
the 1H spectrum is due to presence of a small amount of H2O in the solvent.
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Appendix A (Continued)

Figure A-7. 1H and 13C NMR Spectra of N-Oleoylethanolamine in DMSO-d6.
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Appendix A (Continued)

Figure A-8. 1H and 13C NMR Spectra of N-Benzoylethanolamine in DMSO-d6. Peak at 3.398 ppm in
the 1H spectrum is due to presence of a small amount of H2O in the solvent.
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Appendix A (Continued)

Figure A-9. 1H and 13C NMR Spectra of [1’,2’-13C]-N-Octanoylethanolamine in DMSO-d6. Peak at
3.287 ppm in the 1H spectrum is due to presence of a small amount of H2O in the solvent. 13C-labeled
atoms are denoted by *.
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Appendix A (Continued)

Figure A-10. 1H and 13C Spectra of N-Benzoylglycinal in CDCl3. Peak at 1.598 ppm in the 1H spectrum
is due to presence of a small amount of H2O in the solvent.
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Appendix A (Continued)

Figure A-11. 1H and 13C NMR Spectra of N-Octanoylglycinal in CDCl3.
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Appendix A (Continued)

Figure A-12. 1H and 13C NMR Spectra of N-Octanoylglycinal semicarbazone in DMSO-d6. Peak at
1.598 ppm in the 1H spectrum is due to presence of a small amount of H2O in the solvent. Signal for C atom
marked by † is obscured by the DMSO solvent peak in the 13C spectrum.
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Appendix A (Continued)
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Figure A-13. 1H and 13C NMR Spectra of N-Octanoylglycine in DMSO-d6.
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Appendix A (Continued)

Figure A-14 . 13C NMR spectrum of [1’,2’-13C]-N-octanoylethanolamine control sample without
ADH3.
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Appendix B – HPLC Spectra

(a)

N-benzoylglycine

N-benzoylethanolamine
N-benzoylglycinal

(b)
N-benzoylglycine
O

N-benzoylglycinal
semicarbazone

OH
N
H
O

O

O
N
N
H

N
H

NH2

N-benzoylglycinal
N-benzoylethanolamine
O
OH
N
H

Figure B-1. HPLC separation for N-benzoylethanolamine and its derivatives. (a) Mobile phase:
gradient of 90:10 (50 mM sodium phosphate pH 6.0: CH3CN) to 95:5 over 20 minutes. (b) Mobile phase:
90:10 (50 mM sodium phosphate pH 6.0: CH3CN).
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Appendix B (Continued)

Cinnamic acid

Cinnamyl alcohol

O

OH

Cinnamyl aldehyde

Figure B-2. HPLC separation of cinnamyl alcohol and its derivatives.

N-Octanoylglycinal semicarbazone
Semicarbazide

Figure B-3. HPLC separation of semicarbazide and N-octanoylglycinal semicarbazone.
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Appendix C – GC-MS Spectra

Cinnamyl aldehyde O-PFB-oximes
(E and Z isomers)

PFBHA

77

91

130
F
N

181
F

O

F

F
F

(1E,2E)-cinnamaldehyde O-perfluorobenzyl oxime
Chemical Formula: C16H 10F5NO
Exact Mass: 327.07

Figure C-1. GC-MS Spectra of cinnamyl aldehyde O-PFB-oxime standard.
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Appendix C (Continued)

N,O-di-TMS N-benzoylglycine

N-TMS N-benzoylglycine
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O

308

206

73

77

O
N

Si

73 Si

O

N,O-di-TMS-N -benzoylglycine
Chemical Formula: C15H 25NO 3Si2
Exact Mass: 323.14

105

O

51

206

77

OH
N

73 Si

O

236
N -TMS-N -benzoylglycine
Chemical Formula: C12H17NO3Si
Exact Mass: 251.10

Figure C-2. GC-MS spectra of TMS-derivatized N-benzoylglycine standard.
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Appendix C (Continued)

N-benzoylglycinal-O-PFB-oxime

Figure C-3. GC-MS Spectrum of N-benzoylglycinal O-PFB-oxime standard. E and Z isomers are not
resolved.
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